CHAR Tech Announces Non-Brokered Private Placement of Convertible Debenture Units for Gross Proceeds of up to CDN$3.5 Million and Full Satisfaction of Bioveld Canada Loan
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CHAR Technologies (CTRNF) announced a non-brokered convertible debenture offering to raise up to CDN$3.5 million and plans to settle its Bioveld Canada loan.
The offering comprises up to 3,500 units at CDN$1,000 each. Each includes CDN$1,000 of unsecured debt bearing 8% annual interest, maturing two years after closing and convertible at CDN$0.20 per share, plus 5,000 warrants exercisable at CDN$0.25 for 24 months. Closing is expected on or about November 27, subject to final TSX Venture Exchange acceptance. CHAR Tech intends to fund project development and working capital.
The company anticipates settling the secured loan by November 20, 2026, by transferring $3,779,907 of receivables and debt owed by Char Bioveld Thorold LP, releasing the loan security and all remaining obligations. Bioveld Canada is controlled by director Paul Veldman; the transaction uses exemptions from formal valuation and minority shareholder approval requirements.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Moderate point. Forward-looking: it has not happened yet and may not happen.The proposed offering would raise up to CDN$3,500,000 through up to 3,500 units priced at CDN$1,000 each.
- Moderate point. Forward-looking: it has not happened yet and may not happen.Bioveld loan settlement is anticipated by November 20, 2026, releasing security and eliminating remaining loan obligations.
- Minor point. Forward-looking: it has not happened yet and may not happen.Net proceeds are intended for project development across CHAR Tech's pipeline and general working capital.
Negative
- Moderate point. Forward-looking: it has not happened yet and may not happen.Debentures convertible at CDN$0.20 per share at holders' option create potential shareholder dilution.
- Moderate point. Forward-looking: it has not happened yet and may not happen.Each unit includes 5,000 warrants exercisable at CDN$0.25 for 24 months, creating additional potential dilution.
- Minor point. Forward-looking: it has not happened yet and may not happen.Unsecured debentures add 8% annual interest, payable annually, and mature two years after closing.
- Minor point. Forward-looking: it has not happened yet and may not happen.Offering closing, expected on or about November 27, remains subject to final TSX Venture Exchange acceptance.
- Minor point. Forward-looking: it has not happened yet and may not happen.Loan settlement requires transferring $3,779,907 of existing receivables and debt owed by Char Bioveld Thorold LP.
- Minor point. Forward-looking: it has not happened yet and may not happen.Offering-related finder's fees may be paid, subject to exchange policies and applicable securities laws.
AI-generated analysis. How Rhea-AI works. Not financial advice.
TORONTO, ON / ACCESS Newswire / November 16, 2026 / CHAR Technologies Ltd. ("CHAR Tech" or "the Company") (TSXV:YES)(OTC PINK:CTRNF)(FSE:68K), a leader in sustainable biomass energy solutions, today announced a non-brokered private placement of up to 3,500 convertible debenture units ("the Units") for gross proceeds of up to CDN
Private Placement
Each Unit will be issued at a price of CDN
The Company intends to use the net proceeds of the Offering for project development across the Company's project pipeline and general working capital.
The Units will be offered to purchasers outside Canada pursuant to Section 2.3 of OSC Rule 72-503, and to purchasers in Canada pursuant to available prospectus exemptions. Securities issued to Canadian purchasers and Common Shares issuable upon the conversion or exercise thereof will be subject to a statutory hold period of four months and one day from the date of closing. The Company may pay finder's fees in connection with the Offering, subject to the policies of the TSX Venture Exchange and applicable securities laws. Closing of the Offering is expected on or about November 27th, and remains subject to customary conditions, including final acceptance by the TSX Venture Exchange.
Satisfaction of Bioveld Canada Loan
As announced in the Company's press release dated April 16, 2026, the Company entered into a secured loan agreement with the Lender in connection with its acquisition of biocarbon assets in Saguenay, Québec (the "Loan"). The Company anticipates fully repaying the Loan by November 20th, 2026. All obligations under the Loan will be satisfied through the transfer to the Lender of existing accounts receivable and debt currently owed to the Company by Char Bioveld Thorold LP in the aggregate amount of
The Lender is a related party of the Company because it is controlled by Paul Veldman, a director of the Company. The satisfaction of the loan is therefore a "related party transaction" within the meaning of Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61-101"). The Company is relying on the exemptions from the formal valuation and minority shareholder approval requirements of MI 61-101 contained in sections 5.5(a) and 5.7(1)(a) of MI 61-101, as neither the fair market value of the subject matter of the transaction, nor the fair market value of the consideration for the transaction, insofar as it involves related parties, exceeds
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the " U.S. Securities Act "), or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
About CHAR Technologies Ltd.
CHAR Tech (TSXV:YES; OTC:CTRNF; FSE:68K) is a Canadian clean-technology company developing first-in-kind high-temperature pyrolysis ("HTP") systems that process unmerchantable wood and organic waste to generate two renewable energy revenue streams, renewable natural gas or green hydrogen, and a solid biocarbon that serves as a carbon-neutral, drop-in replacement for metallurgical coal.
CHAR Tech's HTP platform is also advancing a new vertical focused on the permanent destruction of PFAS in wastewater biosolids. Operating at temperatures sufficient to break down long-chain fluorinated compounds, the system enables municipalities and industrial operators to eliminate PFAS while converting biosolids into energy and low-carbon solid products.
For further information, please contact:
| Andrew White Chief Executive Officer CHAR Technologies Ltd. E: andrew.white@chartechnologies.com T: 866 521-3654 | Galen Cranston Director of Stakeholder Relations CHAR Technologies Ltd. E: gcranston@chartechnologies.com T: 647-546-5633 |
Website: www.chartechnologies.com
Neither the TSX Venture Exchange nor its Regulation Service Provider (as the term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the accuracy of this news release.
Forward-Looking Statements
Statements contained in this press release contain "forward-looking information" within the meaning of Canadian securities laws ("forward-looking statements") about CHAR and its business and operations. The words "may", "would", "will", "intend", "anticipate", "expect" and similar expressions as they relate to CHAR Tech, are intended to identify forward-looking information. Forward-looking statements include, but are not limited to, statements relating to the anticipated size of the Offering, the expected closing date of the Offering, the anticipated use of the net proceeds of the Offering, the acceptance of the TSX Venture Exchange, the expected timing and terms of the Loan repayment, and other statements that are not historical facts. These statements assume that the Company will receive subscriptions for the Offering and the acceptance of the TSX Venture Exchange on the terms described, and they are subject to the risk that the Offering may not close on those terms, on the expected date, or at all. Such statements reflect CHAR Tech's current views and intentions with respect to future events, and current information available to CHAR Tech, and are subject to certain risks, uncertainties and assumptions, including, among others, those risk factors discussed or referred to in CHAR Tech's disclosure documents filed with the securities regulatory authorities in certain provinces of Canada, including the Management Discussion & Analysis dated January 27th, 2026 for the fiscal year ended September 30, 2025, and available under CHAR Tech's profile on www.sedarplus.ca. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, CHAR Tech does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and CHAR Tech undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law.
SOURCE: CHAR Technologies Ltd.
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What are the terms of CHAR Technologies' convertible debenture offering?
CHAR Technologies proposes up to 3,500 units at CDN$1,000 each, for gross proceeds of up to CDN$3,500,000. Each unit includes CDN$1,000 of unsecured debentures bearing 8% annual interest and 5,000 warrants. Debentures mature two years after closing and are convertible at CDN$0.20 per share; warrants are exercisable at CDN$0.25 for 24 months.
How will CHAR Technologies settle its Bioveld Canada loan?
CHAR Technologies anticipates fully settling the loan by November 20, 2026, by transferring existing receivables and debt totaling $3,779,907 owed by Char Bioveld Thorold LP. The settlement will release the loan security and leave no remaining obligations under the loan agreement.
Can CHAR Technologies accelerate the private placement warrants' expiry?
CHAR Technologies may accelerate warrant expiry, following notice to holders, if its shares close above CDN$0.29 for 15 consecutive trading days on the TSX Venture Exchange.